Huntington National Bank’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-460
Closed -$9K 1681
2018
Q1
$9K Sell
460
-945
-67% -$22K ﹤0.01% 1353
2017
Q4
$28K Sell
1,405
-328
-19% -$6.45K ﹤0.01% 1134
2017
Q3
$36K Sell
1,733
-95
-5% -$1.61K ﹤0.01% 1064
2017
Q2
$27K Hold
1,828
﹤0.01% 1095
2017
Q1
$29K Hold
1,828
﹤0.01% 1015
2016
Q4
$23K Buy
1,828
+862
+89% +$16.1K ﹤0.01% 1095
2016
Q3
$27K Sell
966
-322
-25% -$10.8K ﹤0.01% 1071
2016
Q2
$45K Buy
+1,288
New +$40.5K ﹤0.01% 953
2016
Q1
Sell
-1,017
Closed -$35K 1874
2015
Q4
$35K Buy
+1,017
New +$31.7K ﹤0.01% 1092

Other funds holding DPLO

Huntington National Bank's DPLO Position: Q2 2018 in Review

Huntington National Bank sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 460 shares — an estimated $9K sold.

Huntington National Bank first reported a position in DPLO in Q4 2015 and held it in 9 quarters. The position peaked at $45K in Q2 2016. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

  • Huntington National Bank reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
  • Huntington National Bank sold 460 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $9K.
  • Huntington National Bank first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 9 quarters.
  • Huntington National Bank's DIPLOMAT PHARMACY, INC. position peaked at $45K in Q2 2016.
  • 206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on Huntington National Bank's 13F filing for Q2 2018, filed 19 Jul 2018.